Antimicrobial Resistance: Q&A with Carb-X About the Fight Against AMR
Kevin Outterson is interviewed.
April 15, 2025 European Biotechnology Life and Science Industry Magazine9th AMR Conference: Novel Antimicrobials & AMR Diagnostics
The AMR Conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and specific challenges faced by the innovation ecosystem in bringing new antimicrobial treatments and diagnostics to the market. The conference is the one-stop shop to catch up with the latest trends in the development of AMR […]
Charting the Path to Tackle Amr: How to Create an Inclusive and Impactful Independent Panel
Kevin Outterson pens an opinion.
January 22, 2025 Center For Global DevelopmentRemembering Professor Virginia “Ginny” Greiman (SED’70, LAW’03)
Virginia “Ginny” Greiman (SED’70, LAW’03), a former deputy chief counsel of Boston’s Big Dig project, an expert in international development who consulted with global institutions such as the World Bank, and a longtime lecturer at Boston University School of Law, died on November 15 after a battle with cancer.
Lessons Learned for AMR Independent Panel
In cooperation with the Quadripartite, representatives from The University in Ibadan, The Center for Global Development, and Boston University will collaboratively lead a strategic dialogue to document and analyze lessons learned from previous initiatives, such as IPCC. This dialogue will bring together a globally representative group of scientists and science academies.
The Superbug Fight Needs a Better Business Model
Kevin Outterson is quoted.
November 19, 2024 Global Health NowAs World’s Health Ministers Meet in Jeddah: Calls for Strong Amr Science Panel with Authority to ‘Challenge’ Sponsors
Kevin Outterson is quoted.
November 14, 2024 Health Policy WatchA Pathogen’s Plight: The International Lethal Pandemic of Antibiotic-Resistant Bacteria
Kevin Outterson is quoted.
November 14, 2024 Glimpse From the GlobeAntimicrobial Resistance Italian Government Gives $21 Million to BU-Led Effort to Develop New Antibiotics, Vaccines, Diagnostics
Kevin Outterson is interviewed.
October 22, 2024 Boston UniversityWhat Happens When the Last AMR Researcher Turns Off the Lights in the Lab?
Kevin Outterson is quoted.
August 21, 2024 Infectious Disease Special Edition